Best Laxative to Take with Ozempic: UK Clinical Guidance Ozempic (semaglutide), a GLP-1 receptor agonist used for type 2 diabetes and weight management, commonly causes constipation by slowing gastrointestinal motility
For example, the Northwest Region cited above says it covers Ozempic for weight management if the patient has a BMI of 30 kg/m2 or more, or if they have a BMI of 27 kg/m2 or more plus diagnosed hypertension, Type 2 diabetes, or hyperlipidemia
Semaglutide does not directly cause tumors
Key takeaway Both medicines can support significant weight loss, especially at the higher, weight-management doses (Wegovy for semaglutide and Zepbound for tirzepatide)
Safety, Cost, and Coverage Side-effects: Commonnausea, reflux, constipation
For expedited and international shipping options please contact one of our Patient Service Representatives